Showing Results : 1-1 of 1
Sort By :
  • Dermatology and Therapy: 2023, vol: 13, issue: 11
  • 1)- Howa Yeung, Yin Li, Robert A Swerlick. The Changing Tasks of Medicine and Dermatology in the Twenty-First Century: The Need for Improved Information Capture Tools and Processes. Dermatology and therapy. 2023, 13 (11): 2479-2486
    Cited : 0
    Read More
  • 2)- Hannah Penton, Sayeli Jayade, Santhani Selveindran, Marieke Heisen, Christophe Piketty, Liliana Ulianov, Zarif K Jabbar-Lopez, Jonathan I Silverberg, Jorge Puelles. Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical Trials. Dermatology and therapy. 2023, 13 (11): 2549-2571
    Cited : 0
    Read More
  • 3)- Thomas B Casale, Ana Maria Gimenez-Arnau, Jonathan A Bernstein, Michael Holden, Torsten Zuberbier, Marcus Maurer. Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status. Dermatology and therapy. 2023, 13 (11): 2573-2588
    Cited : 1
    Read More
  • 4)- April W Armstrong, Sang Hee Park, Vardhaman Patel, Malcolm Hogan, Wei-Jhih Wang, David Davidson, Viktor Chirikov. Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis. Dermatology and therapy. 2023, 13 (11): 2605-2607
    Cited : 0
    Read More
  • 5)- Michael J Cork, Diamant Thaçi, Lawrence F Eichenfield, Peter D Arkwright, Zhen Chen, Ryan B Thomas, Matthew P Kosloski, Ariane Dubost-Brama, Randy Prescilla, Ashish Bansal, Noah A Levit. Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis. Dermatology and therapy. 2023, 13 (11): 2697-2719
    Cited : 3
    Read More
  • 6)- Byung Soo Kim, Seong Jin Jo, SangWoong Youn, Kristian Reich, Carine Saadoun, Chia-Ling Chang, Ya-Wen Yang, Yu-Huei Huang, Tsen-Fang Tsai. Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2. Dermatology and therapy. 2023, 13 (11): 2721-2737
    Cited : 0
    Read More
  • 7)- Robert R McLean, Adam P Sima, Silky Beaty, Robert Low, Rebecca L Spitzer, Jeffrey L Stark, Elizabeth Lesser, Edward Lee, April Armstrong. Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry. Dermatology and therapy. 2023, 13 (11): 2739-2751
    Cited : 0
    Read More
  • 8)- Robert R McLean, Adam P Sima, Silky Beaty, Eric A Jones, Thomas Eckmann, Robert Low, Laura McClung, Rebecca L Spitzer, Jeffrey Stark, April Armstrong. Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry. Dermatology and therapy. 2023, 13 (11): 2753-2768
    Cited : 1
    Read More
  • 9)- Serena Manara, Francesco Beghini, Giulia Masetti, Federica Armanini, Davide Geat, Giulia Galligioni, Nicola Segata, Stefania Farina, Mario Cristofolini. Thermal Therapy Modulation of the Psoriasis-Associated Skin and Gut Microbiome. Dermatology and therapy. 2023, 13 (11): 2769-2783
    Cited : 3
    Read More
  • 10)- Kinga Tyczyńska, Piotr K Krajewski, Danuta Nowicka-Suszko, Dariusz Janczak, Hanna Augustyniak-Bartosik, Magdalena Krajewska, Jacek C Szepietowski. Neurotrophin-4 and Brain-Derived Neurotrophic Factor Serum Levels in Renal Transplant Recipients with Chronic Pruritus. Dermatology and therapy. 2023, 13 (11): 2785-2796
    Cited : 0
    Read More
  • 11)- Ericles Andrei Bellei, André Vicente Esteves de Carvalho, Beatriz Magalhães Eng, Carla Tozato, Danilo Hamilko de Barros, Erika Yumi Tamashiro, Gleison Vieira Duarte, Rafael Toledo Rodrigues de Fátima, Renata Ferreira Magalhães, Roberto Souto da Silva, Wagner Guimarães Galvão Cesar, Felipe Garutti Thies. Navigating the Multidimensional Impact of Living with Hidradenitis Suppurativa: An In-Depth Netnographic Study on Social Media Platforms. Dermatology and therapy. 2023, 13 (11): 2797-2815
    Cited : 0
    Read More
  • 12)- Aoife Mahon-Smith, George Skingley, Lara Ayala-Nunes, Anjali Batish, Rosie Sharp, Christel Naujoks, Eva Schruf, Nicolò Compagno, Santiago G Moreno. Evaluating the Appropriateness of Existing Health-Related Quality of Life Measures in Lichen Planus. Dermatology and therapy. 2023, 13 (11): 2817-2837
    Cited : 0
    Read More
  • 13)- April W Armstrong, Richard B Warren, Yichen Zhong, Joe Zhuo, Allie Cichewicz, Ananth Kadambi, Daniela Junqueira, Tracy Westley, Renata Kisa, Carolin Daamen, Matthias Augustin. Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-Analysis. Dermatology and therapy. 2023, 13 (11): 2839-2857
    Cited : 5
    Read More
  • 14)- Riley K Spencer, Joy Q Jin, Kareem G Elhage, Mitchell S Davis, Marwa Hakimi, George Gondo, Wilson Liao, Tina Bhutani. Association Between Poor Sleep and Myocardial Infarction in Patients with Psoriasis: Findings from a Cross-Sectional Study with the National Psoriasis Foundation. Dermatology and therapy. 2023, 13 (11): 2903-2909
    Cited : 0
    Read More
  • 15)- Andrew Blauvelt, Alyssa Garrelts, William Malatestinic, Julie Birt, Baojin Zhu, Meghan Feely. Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA. Dermatology and therapy. 2023, 13 (11): 2911-2916
    Cited : 1
    Read More
  • 16)- Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Patrick Lefebvre, Steven R Feldman. Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA. Dermatology and therapy. 2023, 13 (11): 2917-2923
    Cited : 0
    Read More
 
 


Journal List
Links
Content Links
About Us

0